En del af Watch Medier
Biotekfirmaet Elion Therapeutics fra New York har hentet 81 mio. dollar, 564 mio. kr., fra antibiotikafonden AMR Action Fond og Deerfield Management samt Illinois Ventures.
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.
Nyhedsbrevsvilkår
For abonnenter
For abonnenter
For abonnenter
For abonnenter
For abonnenter
For abonnenter
Quality Engineer for Production
Global Head of Rewards
Senior Legal Counsel
Principal Bioinformatic Scientist, Antibody Technology
Healthcare Compliance Senior Specialist (Associated Director), Ascendis Pharma
QA Manager GMP
Produktionskemiker
Investor Relations Manager
Material Scientist and Coordinator
QA/RA Specialist, Patient Handling Division
(Senior) Drug Substance Specialist
Skilled Process Specialist for managing logistic and production processes in SAP
Environmental Monitoring Professional
.jpg&w=384&q=75)
Department Manager for Chemistry at Minerva Imaging
Business Development Manager
Kvalitetsingeniør GMP Pharma, Krüger
Head of OTC Product Development
Governmental Public Affairs & Communications Head
Medical Director
QP delegate Biologics, CMC
Head of Quality Assurance
ESG Officer
Principal Quality Assurance Professional – Combination Products
Senior Consultant / Project Manager - Life Science (R&D & Clinical)
